1. Home
  2. BNR vs HRZN Comparison

BNR vs HRZN Comparison

Compare BNR & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$22.81

Market Cap

252.7M

Sector

Health Care

ML Signal

N/A

Logo Horizon Technology Finance Corporation

HRZN

Horizon Technology Finance Corporation

N/A

Current Price

$4.24

Market Cap

295.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
HRZN
Founded
2014
2008
Country
China
United States
Employees
674
N/A
Industry
Medical Specialities
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
252.7M
295.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
HRZN
Price
$22.81
$4.24
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$6.80
AVG Volume (30 Days)
13.1K
1.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
30.99%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$136.32
$19.99
Revenue Next Year
N/A
$27.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.18
$4.00
52 Week High
$41.72
$9.52

Technical Indicators

Market Signals
Indicator
BNR
HRZN
Relative Strength Index (RSI) 40.95 17.25
Support Level $7.99 N/A
Resistance Level $24.23 $6.81
Average True Range (ATR) 2.07 0.25
MACD -0.41 -0.21
Stochastic Oscillator 29.88 9.57

Price Performance

Historical Comparison
BNR
HRZN

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About HRZN Horizon Technology Finance Corporation

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.

Share on Social Networks: